RESUMEN
BACKGROUND: Drug-coated balloon (DCB) angioplasty and drug-eluting stents (DES) are two widely used treatments for in-stent restenosis (ISR). Focal and non-focal types of ISR affect the clinical outcomes. The present study aims to compare DES reimplantation versus DCB angioplasty in acute coronary syndrome (ACS) patients with focal ISR and non-focal ISR lesions. METHODS: Patients with ISR lesions underwent percutaneous coronary intervention (PCI) were retrospectively evaluated and divided into DES group and DCB group. The primary endpoint was the incidence of target lesion failure (TLF) at 24 months follow up. Propensity score matching (PSM) was conducted to balance the baseline characteristics. RESULTS: For focal ISR, TLF was comparable in the DES and DCB groups at 24 months of follow-up (Before PSM, hazard ratio [HR]: 0.70; 95% confidence interval [CI]: 0.39-1.27; p = 0.244; After PSM, HR: 0.83; 95% CI: 0.40-1.73; p = 0.625). For non-focal ISR, TLF was significantly decreased in DES compared with DCB group (Before PSM, HR: 0.43; 95% CI: 0.29-0.63; p < 0.001; After PSM, HR: 0.33; 95% CI: 0.19-0.59; p < 0.001), which was mainly attributed to the lower incidence of clinically indicated target lesion revascularization (CD-TLR) (Before PSM, HR: 0.39; 95% CI: 0.26-0.59; p < 0.001; After PSM, HR: 0.28; 95% CI: 0.15-0.54; p < 0.001). CONCLUSIONS: The clinical outcomes for DES and DCB treatment are similar in focal type of ISR lesions. For non-focal ISR, the treatment of DES showed a significant decrease in TLF which was mainly attributed to a lower incidence of CD-TLR.
RESUMEN
SSZ-13 zeolite has been identified as effective material for catalysts and membranes for years because of its structure, but the long crystallization time is the main obstacle for the industry application. The sonochemical-assisted method was identified as one of the potential pre-treatment methods which could reduce the formation duration of zeolites as well as other microporous and mesoporous materials. In this work, zeolite SSZ-13 was prepared by ultrasound pretreatment prior to hydrothermal crystallization. For comparison, samples by the conventional pretreatment and hydrothermal method were also prepared. The synthesized powders were characterized by XRD, SEM, BET, FTIR, NMR and TGA. The results showed that the complete crystallization of SSZ-13 synthesized by the ultrasound-assisted hydrothermal method was achieved within 72h, and much faster than conventional hydrothermal synthesis (120h). Furthermore, the ultrasound pretreatment showed very little effect on the structure properties of the final product compared with the conventional aging method.
